COMPARATIVE STUDY OF CLINICAL EFFICACY OF DILTIAZEM AND PROPRANOLOL IN PATIENTS WITH HYPERTHYROIDISM
Main Article Content
Objective: To compare the efficacy of diltiazem and propranolol in controlling the adrenergic manifestations of hyperthyroidism.
Material and Methods: This prospective, interventional study included 44 newly diagnosed, untreated patients with hyperthyroidism attending the out patient department of Institute of Radiotherapy and Nuclear Medicine, Peshawar. Patients were randomized to two matched groups. Group I (n = 23, mean age 37.91 + 10.48 years) took diltiazem 30 mg three times a day for 6 weeks. Group II (n = 21, mean age 37.57 + 14.27 years) took propranolol 20 mg three times a day for a period of 6 weeks. Clinical assessment was done before starting therapy and then after 6 weeks (+ 3 days) using standardized and
modified hyperthyroid symptom score (HSS).
Results: HSS decreased from 16.35 + 2.31 to 11.26 + 2.56 in group I after 6 weeks of therapy with diltiazem (P < 0.001). HSS declined from 15.62 + 2.25 to 11.38 + 2.13 in group II after 6 weeks of therapy with propranolol (P < 0.001).
Conclusion: Diltiazem, like propranolol, effectively controls the clinical manifestations of
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.